COMMUNIQUÉS West-GlobeNewswire

AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
12/02/2026
VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ® , Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company [...]
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/02/2026
LEXINGTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]
Ultragenyx Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Update
12/02/2026
2025 total revenue of $673 million, Crysvita ® revenue of $481 million and Dojolvi ® revenue of $96 million 2026 total revenue from current products expected to be between $730 million to $760 million Initiated a [...]
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
12/02/2026
AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31 [...]
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
12/02/2026
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET / 22:30 CET IRVINE, [...]
PacBio Announces Fourth Quarter and Full Year 2025 Financial Results
12/02/2026
MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results: Q4 2025 Q4 [...]
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
12/02/2026
ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. “As we close out the [...]
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
12/02/2026
Press Release – No. 3 / 2026 Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results Copenhagen, Denmark, February 12, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR- [...]
GENFIT va recevoir un paiement d’étape de 20 M$ suite au dépassement du seuil des 200 M$ de ventes nettes d’Iqirvo® par Ipsen dès sa première année complète de commercialisation
12/02/2026
Ventes nettes d’Iqirvo® dans la PBC par Ipsen atteignant 88 M$ au 4T25, portant le total annuel pour 2025 à 208 M$, déclenchant le premier paiement d’étape 1 commercial pour GENFIT plus tôt que prévu Confirmation par [...]
Pennant Announces Fourth Quarter and Year-End 2025 Earnings Release and Call
12/02/2026
EAGLE, Idaho, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Beacon Behavioral Partners Expands into South Carolina with Carolina Psychiatry
12/02/2026
New partner brings advanced depression treatments to Anderson, Greenville, Seneca, and Spartanburg BATON ROUGE, La., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Beacon Behavioral Partners (BBP), a physician-driven organization [...]
FDA Approves Labeling Changes to Menopausal Hormone Therapy Products
12/02/2026
White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to [...]
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
12/02/2026
Ipsen reported US$88M of Iqirvo® net sales in PBC for 4Q25, bringing 2025 sales to US$208M, triggering the first commercial milestone payment to GENFIT ahead of schedule 1 Ipsen confirmed its commitment to launch a [...]
Canadian Red Cross launches appeal to support people impacted by the tragedy in Tumbler Ridge, B.C.
12/02/2026
OTTAWA, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working to support those impacted by the tragedy in Tumbler Ridge, B.C., and has launched the Tumbler Ridge Tragedy Appeal. Money raised will [...]
Northwestern Medicine and Founders Factory to scale European AI ventures into America’s leading health system
12/02/2026
AI is driving healthcare’s next wave: AI and deeptech advancements are transforming healthcare infrastructure, delivering novel approaches to safer, more efficient and more personalised patient care Advancing innovation [...]
La Croix-Rouge canadienne recueille des dons pour venir en aide aux personnes éprouvées par la tragédie à Tumbler Ridge, en Colombie-Britannique
12/02/2026
OTTAWA, Ontario, 12 févr. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne s’emploie à soutenir les personnes touchées par la tragédie survenue à Tumbler Ridge, en Colombie-Britannique. L’organisation a mis sur pied [...]
FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer
12/02/2026
Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult [...]
Invitation to Idorsia's FY 2025 Financial Reporting webcast and conference call
12/02/2026
Idorsia will publish its Full Year 2025 Financial Reporting on Thursday February 26, at 07:00 CET. An investor webcast and conference call will be held to discuss the results on the same day. Date: Thursday, February 26 [...]
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
12/02/2026
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease- [...]

Pages